Bayer agrees to $7.25 billion proposed settlement over thousands of Roundup cancer lawsuits

Bayer has reached a proposed settlement of $7.25 billion to resolve thousands of lawsuits alleging that its popular weedkiller, Roundup, can cause cancer. The lawsuits claim that Bayer failed to adequately warn consumers about the potential cancer risks associated with glyphosate, the active ingredient in Roundup. This settlement was announced on Tuesday and involves attorneys representing cancer patients. The proposed settlement comes at a time when the U.S. Supreme Court is preparing to hear arguments regarding Bayer's assertion that the Environmental Protection Agency's (EPA) approval of Roundup without a cancer warning should invalidate claims filed in state courts. It is important to note that this ongoing Supreme Court case would not be affected by the proposed settlement. Bayer, a German chemical giant, has faced thousands of lawsuits related to Roundup, which has been a widely used herbicide. The settlement aims to address the legal challenges the company has faced due to allegations of not providing sufficient warnings about the potential health risks of its product. The agreement represents a significant financial commitment by Bayer to resolve these legal disputes. The proposed settlement has been reported by multiple news outlets, including Deutsche Welle, The Guardian, AP News, Reuters, and CBS News, highlighting the widespread attention this issue has garnered in the media.